NOTICE

Last week, SJ Park, Ph. D., CEO of Onegene Biotechnology, gave a lecture on Unistac® platform, next generation of multi-specific antibody, at ASK(The Antibody Society Korea) 2022. Dr. Park, presented how Onegene Biotechnology approaches to drug development for complicated diseases with Unistac® platform.